Evidence map›Paper›PMID 31035951›Full record

ArticleBMC cancer2019

Hsa_circ_0005379 regulates malignant behavior of oral squamous cell carcinoma through the EGFR pathway.

Wen Su, Yufan Wang, Feng Wang, Shuai Sun, Minghua Li, Yuehong Shen, Hongyu Yang

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2021
    Article
  17. Review
  18. Exosomal circRNAs: a new communication method in cancer.American journal of translational research · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Wen SuDepartment of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, No. 1120 Lianhua Road, Shenzhen, 518001, Guangdong, China.
Yufan WangDepartment of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, No. 1120 Lianhua Road, Shenzhen, 518001, Guangdong, China.
Feng WangDepartment of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, No. 1120 Lianhua Road, Shenzhen, 518001, Guangdong, China.
Shuai SunDepartment of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, No. 1120 Lianhua Road, Shenzhen, 518001, Guangdong, China.
Minghua LiCentral laboratory, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
Yuehong ShenDepartment of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, No. 1120 Lianhua Road, Shenzhen, 518001, Guangdong, China. yuehongshen@hotmail.com.ORCID http://orcid.org/0000-0001-8080-7039
Hongyu YangDepartment of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, No. 1120 Lianhua Road, Shenzhen, 518001, Guangdong, China. hyyang192@hotmail.com.ORCID http://orcid.org/0000-0002-0367-4938
Peking University Shenzhen Hospital · CNAnhui Medical University · CN

Funding

National Natural Science Foundation of China 81572654Shenzhen Science and Technology Innovation Commission JCYJ20150403091443286 and SZBC2017023Shenzhen Science and Technology Innovation Commission JCYJ20160428173933559, JCYJ20150403091443303
6 · The paper itself

Abstract

backgroundOral squamous cell carcinoma (OSCC) is an oral and maxillofacial malignancy with a high incidence worldwide. Accumulating evidence indicates that circular RNAs (circRNAs) play a vital role in modulating tumor development. However, the mechanism of circRNA action in human OSCC remains largely unknown.

methodsBy using high-throughput transcriptome sequencing technology, we conducted a comprehensive study of circRNAs in human OSCC. The effect of circRNA hsa_circ_0005379 on OSCC tissues and cell lines was monitored by qRT-PCR, Transwell assay, flow cytometry, and western blot analysis. Xenograft mouse models were used to assess tumor growth and animal survival.

resultsWe found that circRNA hsa_circ_0005379 expression is significantly lower in OSCC tissue compared to paired non-cancerous matched tissue and is associated with tumor size and differentiation. Overexpression of hsa_circ_0005379 effectively inhibits migration, invasion, and proliferation of OSCC cells in vitro and suppresses OSCC growth in nude mice in vivo. Mechanistic studies revealed that hsa_circ_0005379 may be involved in the regulation of the epidermal growth factor receptor (EGFR) pathway. Furthermore, we found that high expression of hsa_circ_0005379 could significantly enhance the sensitivity of OSCC to the cetuximab drug.

conclusionsOur findings provide evidence that hsa_circ_0005379 regulates OSCC malignancy and may be a new therapeutic target for OSCC treatment.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsAntineoplastic Agents, ImmunologicalCarcinoma, Squamous CellCell LineCell Line, TumorCells, CulturedCell SurvivalCetuximabErbB ReceptorsFemaleHumansMaleMice, Inbred BALB CMice, NudeMiddle AgedAntineoplastic Agents, ImmunologicalCetuximabEGFR protein, humanErbB ReceptorsRNARNA, CircularCetuximabCircular RNAsEGFR pathwayEpithelial–mesenchymal transitionOral squamous cell carcinoma

Identifiers

PMID31035951
PMCPMC6489207
OpenAlexW2947755469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.